...
首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: A meta-analysis of 56 cases
【24h】

Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: A meta-analysis of 56 cases

机译:具有增生生发中心的血管免疫母细胞性T细胞淋巴瘤(模式1)的存活率优于模式2和3:56例患者的荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: Angioimmunoblastic T-cell lymphoma (AITL) may present in patterns 1, 2 or 3, representing those with hyperplastic, regressed or effaced germinal centres (GCs), respectively, but the prognostic utility of this subclassification has not been previously validated. Methods and results: Twenty-five cases of AITL were reviewed immunohistologically and with in-situ hybridization for Epstein-Barr virus-encoded RNA and polymerase chain reaction for T-cell receptor gamma and immunoglobulin heavy chain clonality and followed for up to 120months. Four cases had conventional hyperplastic GCs, two had floral GCs, and one had progressively transformed GCs, consistent with pattern 1 and one additional case had hyalinized GCs, consistent with pattern 2. The remaining 17 (pattern 3) cases lacked morphologically discernible GCs. The Kaplan-Meier survival distribution of pattern 1 cases (5-year survival 83%) was superior to that of pattern 2 and 3 cases [5-year-survival 36% (P=0.0417)] only when combined with the 31 cases, seven of which were pattern 1, that Attygalle et al. had followed for up to 247months and previously published. Furthermore, the development of B-lineage (classical Hodgkin or diffuse large-cell) lymphoma was associated exclusively with pattern 3 (P=0.0057). Conclusions: Pattern 1 represents an indolent phase/grade of AITL, unassociated with the development of secondary B-lineage lymphoma and uninfluenced by treatment regimen.
机译:目的:血管免疫母细胞性T细胞淋巴瘤(AITL)可能以1、2或3型出现,分别代表增生性,退行性或消失的生发中心(GCs),但该分类的预后效用尚未得到证实。方法和结果:对25例AITL进行了免疫组织学检查,并就爱泼斯坦-巴尔病毒编码的RNA进行了原位杂交,并对T细胞受体γ和免疫球蛋白重链克隆性进行了聚合酶链反应,随访了120个月。 4例具有常规增生性GC,2例具有花卉GC,1例逐渐转化GC,与模式1一致,另外1例具有透明质化GC,与模式2一致。其余17例(模式3)缺乏形态学上可辨别的GC。仅当与31例患者合并使用时,模式1例(5年生存率83%)的Kaplan-Meier生存分布优于模式2和3例[5年生存率36%(P = 0.0417)]。其中有七个是模式1,即Attygalle等。已进行长达247个月的跟踪研究,并已发布。此外,B谱系(经典霍奇金或弥漫性大细胞)淋巴瘤的发生仅与模式3相关(P = 0.0057)。结论:模式1代表AITL的惰性阶段/等级,与继发性B谱系淋巴瘤的发生无关,并且不受治疗方案的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号